WATERTOWN, Mass., Sept. 28, 2016 -- For the seventh year in a row, pediatricians ranked temporal artery thermometry (TAT) number one in overall preference over any other thermometry method, according to a recent survey of physicians. Of the 268 survey respondents, 40.5 percent ranked TAT number one based on overall performance, compared to rectal, ear, oral and axillary thermometry. In addition, more than half (57.3 percent) of pediatricians ranked TAT number one in ease of use.
The new study further shows that Exergen is used and recommended more than any other thermometer brand – 42 percent of pediatricians use the Exergen TAT and 36 percent recommend it to their patients, ranking highest in both categories. In addition, the results show that nearly two-thirds of pediatricians (64.4 percent) who use or recommend Exergen temporal artery thermometers do so for patients of all ages, the highest percentage of any thermometer.
“We are pleased to see that pediatricians continue to embrace and recommend temporal artery thermometry over all other methods, and that the number of those physicians is steadily increasing,” said Dr. Francesco Pompei, CEO of Exergen Corporation. "With more than 60 clinical studies supporting its accuracy, physicians have come to trust and rely on the TemporalScanner. It is non-invasive, easy to use and accurate, which enhances the physician-patient bond."
Survey respondents noted strengths of temporal artery thermometry, including ease of use and accuracy. The survey also captured pediatricians' commentary about temporal artery thermometry. According to one physician respondent, "Temporal Artery Exergen has made my life very easy!" Another respondent said, “Temporal Artery is easy to use for nurse, patient and family.”
The survey was conducted by Pragmatic Research, Inc. and pediatricians were not told that it was sponsored by Exergen. The results were consistent with other independent research involving nurses and other healthcare professionals in various clinical settings.
ABOUT EXERGEN CORPORATION
Exergen Corporation is a recognized world leader in industrial and medical non-invasive temperature technology. The company manufactures and markets TemporalScanner thermometer models for hospitals and clinics, and consumer models sold in major retailers nationwide. Nearly two billion temperatures are taken each year with Exergen TemporalScanners in thousands of hospitals, clinics and pediatricians' offices across the country, as well as in millions of homes. It is the #1 preference of pediatricians, nurses, and mothers and is the #1 selling retail thermometer. The Exergen TemporalScanner’s performance is supported by more than 60 peer-reviewed published studies covering all ages from preterm infants to geriatrics, and all care areas from hospitals to homes. For additional information, visit www.exergen.com.
Contact: Victoria Day Rosica Public Relations [email protected] P: 201.843.5600 F: 201.843.5680 21-00 Route 208 South, Suite 130 Fair Lawn, NJ 07410


U.S. Lawmakers Urge Pentagon to Blacklist More Chinese Tech Firms Over Military Ties
FedEx Beats Q2 Earnings Expectations, Raises Full-Year Outlook Despite Stock Dip
Elon Musk Wins Reinstatement of Historic Tesla Pay Package After Delaware Supreme Court Ruling
Sanofi’s Efdoralprin Alfa Gains EMA Orphan Status for Rare Lung Disease
Toyota to Sell U.S.-Made Camry, Highlander, and Tundra in Japan From 2026 to Ease Trade Tensions
Trump Signals Push for Lower Health Insurance Prices as ACA Premium Concerns Grow
Delta Air Lines President Glen Hauenstein to Retire, Leaving Legacy of Premium Strategy
Oracle Stock Surges After Hours on TikTok Deal Optimism and OpenAI Fundraising Buzz
Volaris and Viva Agree to Merge, Creating Mexico’s Largest Low-Cost Airline Group
7-Eleven CEO Joe DePinto to Retire After Two Decades at the Helm
Oracle Stock Slides After Blue Owl Exit Report, Company Says Michigan Data Center Talks Remain on Track
ANZ New CEO Forgoes Bonus After Shareholders Reject Executive Pay Report
Union-Aligned Investors Question Amazon, Walmart and Alphabet on Trump Immigration Policies
OpenAI Explores Massive Funding Round at $750 Billion Valuation
Boeing Seeks FAA Emissions Waiver to Continue 777F Freighter Sales Amid Strong Cargo Demand
Bridgewater Associates Plans Major Employee Ownership Expansion in Milestone Year
Micron Technology Forecasts Surge in Revenue and Earnings on AI-Driven Memory Demand 



